In AD patients, it is observed the decreased uptake of insulin into brain and decreased CSF level of insulin [93], which is probably related to mis‐localized (not on the membrane surface), or reduced INSR on BBB, or decreased receptor affinity for insulin [210]. The gene discussed is INS; the disease is Alzheimer disease.